~~<i id='855522410C'><strike id='855522410C'><tt id='855522410C'><pre id='855522410C'></pre></tt></strike></i>~~

Home» focus» Wikipedia

Wikipedia

author：hotspot 2025-10-02 08:28:07 Page View：4

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end
Next article： Sports medicine is finally prioritizing gender equality

explore

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

FILE-ThisundatedphotoprovidedbyWashingtonCounty,Ark.,DetentionCentershowsJoshDuggar.Afederalappealsc

Trump demands the U.S. pay no more for drugs than other countries … again

EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

Medicare Advantage beneficiaries sue Humana over algorithm use

AdobeMedicareAdvantagebeneficiariesonTuesdayfiledaclass-actionlawsuitallegingthatthehealthinsuranceg